Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.51 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4468998 | 0.80 | ADRB1 (0.51) | LMNAALDH1A1CYP1A2CYP2C19TSHR | |
| SCHEMBL5543471 | 0.80 | MAPK1 (0.51) | LMNAALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL11666677 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4CYP2C19KMT2A | |
| SCHEMBL11666671 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4CYP2C19KMT2A | |
| SCHEMBL8342797 | 0.77 | ALDH1A1 (0.55) | LMNAALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL6228918 | 0.77 | ALDH1A1 (0.52) | LMNAALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL9424371 | 0.77 | ALDH1A1 (0.49) | LMNAALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL5542939 | 0.77 | ALDH1A1 (0.52) | ALDH1A1CYP1A2CYP3A4CYP2C19KMT2A | |
| SCHEMBL20910885 | 0.77 | ALDH1A1 (0.68) | ALDH1A1CYP1A2CYP3A4CYP2C19KMT2A | |
| Hydrochloric Acid SCHEMBL5339525 | 0.76 | ALDH1A1 (0.51) | ALDH1A1CYP1A2CYP3A4CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119173603-A | Composition for adhesive, hot melt adhesive composition, and adhesive | 日本瑞翁株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-113288817-B | Dental materials based on cyclizable polymeric crosslinkers | 义获嘉伟瓦登特公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-116940647-A | Curable adhesive composition comprising maleimide and thiol | 汉高股份有限及两合公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-114729156-A | Shaped dielectric component crosslinked by irradiation and method of making same | 罗杰斯公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-3861976-B1 | DENTAL MATERIALS BASED ON CYCLOPOLYMERISABLE CROSS-LINKING AGENTS | IVOCLAR VIVADENT AG (LI) | 2022-03-30 | — | — | EP | disclosed |
| CN-110072686-B | Flexographic platemaking machine and method for making flexographic plate | 爱克发有限公司 | 2021-09-28 | — | — | CN | disclosed |
| EP-3861976-A1 | DENTAL MATERIALS BASED ON CYCLOPOLYMERISABLE CROSS-LINKING AGENTS | Ivoclar Vivadent AG (LI) | 2021-08-11 | — | — | EP | disclosed |
| CN-108698398-B | Customizable printing plate and method of making same | 麦克德米德图像方案股份有限公司 | 2020-09-15 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | LMNA 4152/4885ALDH1A1 355/4885CYP1A2 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.